Search results
Eli Lilly's Potential Alzheimer’s Drug Clears a Big Hurdle
Time via Yahoo News· 18 hours agoNot all hospitals have such experts available. Second, the company allowed some patients in the...
Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
Zacks via Yahoo Finance· 23 hours agoLilly’s biologics license application (BLA) is seeking approval of donanemab for the treatment of...
Thousands face missing out on new Alzheimer’s treatments unless testing overhauled
The Telegraph via Yahoo News· 7 hours agoNew drugs, called lecanemab and donanemab, slow down the early stages of the disease by helping to...
Donanemab approval would fuel growth of amyloid-blocking Alzheimer’s drugs, analysts say
BioPharma Dive via Yahoo Finance· 1 day ago“A rising tide lifts all boats, in our view,” wrote Myles Minter, an analyst at William Blair, in a...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 19 hours agoEli Lilly stock is trading at a record high as enthusiasm grows for its Alzheimer's treatment,...
FDA advisory panel recommends new Alzheimer's drug after scrutiny
United Press International via Yahoo News· 22 hours agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 26 minutes agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
Study finds cognitive training less effective in healthy older adults with beta-amyloid deposits
Medical Xpress· 2 days agoThe presence of beta-amyloid deposits in the brain significantly limits the effectiveness of cognitive training in healthy older adults, according to new research presented ...
Novel Method Able to Predict if, When, Dementia Will Develop
Medscape· 1 day agoThe results suggest resting-state functional MRI (rs-fMRI) could be used to identify a neural...
Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
Investor's Business Daily· 16 hours agoLilly's donanemab as well as Biogen and Eisai's Leqembi work by clearing abnormal plaque called ...